Stem Cell Reviews and Reports

, Volume 11, Issue 3, pp 526–532 | Cite as

Comparison of Therapeutic Characteristics of Islet Cell Transplantation Simultaneous with Pancreatic Mesenchymal Stem Cell Transplantation in Rats with Type 1 Diabetes Mellitus

  • Ilknur Ozturk UnsalEmail author
  • Zeynep Ginis
  • Ferda Alparslan Pinarli
  • Aynur Albayrak
  • Erman Cakal
  • Mustafa Sahin
  • Tuncay Delibasi


Although, pancreas islet call transplantation is a new, promising method for type 1 diabetic patients, it remains as an experimental procedure applied in selected patients. The present study aimed to investigate effect of pancreatic mesenchymal stem cell transplantation simultaneous with islet cell transplantation on islet liveliness and thus on the treatment of diabetes in type 1 diabetic rats. The study used Wistar Albino Rats and was performed in a total of four groups [control (G1), mesenchymal stem cell (G2), islet (G3) and islet + mesencymal stem cell (G4)] each including 8 rats. Blood glucose level of the rats, in which diabetes model has been created using streptozotocin, was measured after 72 h. Blood samples were obtained from the rats 30 days after transplantation and then, their livers and pancreases were kept in 10 % formaldehyde and the experiment was ended. Following staining with H&E, they were morphologically evaluated under a light microscope. Change in mean blood glucose level was statistically significant in G3 and G4 versus G1 and G2 (p = 0.001, p < 0.001, p < 0.001, and p < 0.001 respectively). Histological examination revealed that mean number of islet cells in the pancreases of the rats was higher in G4; difference between the groups was statistically significant (p < 0.001). Transplantation of islet cells together with mesenchymal stem cells showed beneficial effects in terms of prolonging survival of islet grafts suggesting that transplantation of mesenchymal stem cells together with islet cells during clinical islet transplantation may be beneficial in increasing the number of noninsulin-dependent patients in Type 1 diabetes.


Islet Mesenchymal stem cell Diabetes mellitus Cell trasplatation Pancreas 



Diabetes mellitus


Mesenchymal stem cells


Fluorescein diacetate


Propidium iodide






Fluorescein isothiocyanate


Intraperitoneal glucose tolerant test


Conflicts of interest

There are no conflicts of interest for all authors.


  1. 1.
    Larsen, C. E., & Alper, C. A. (2004). The genetics of HLA-associated disease. Current Opinion in Immunology, 16(5), 660.CrossRefPubMedGoogle Scholar
  2. 2.
    DCCT. The Diabetes Control and Complications Trial Research Group The Effect of Intensive. (1993). Treatment of diabetes on the development and progression of long-term complications in ınsulin-dependent diabetes mellitus. New England Journal of Medicine, 329, 977–986.CrossRefGoogle Scholar
  3. 3.
    Atkinson, M. A., & Eisenbarth, G. S. (2001). Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet, 358, 221–985.CrossRefPubMedGoogle Scholar
  4. 4.
    Cryer, P. E. (2005). Mechanisms of hypoglycemia-associated autonomic failure and ıts component syndromes in diabetes. Diabetes, 54(12), 3592–3601.CrossRefPubMedGoogle Scholar
  5. 5.
    Cryer, P. E. (2008). The barrier of hypoglycemia in diabetes. Diabetes, 57(12), 3169–3176.CrossRefPubMedCentralPubMedGoogle Scholar
  6. 6.
    Edlund, H. (2002). Pancreatic organogenesis–developmental mechanisms and implications for therapy. Nature Reviews Genetics, 3, 524–532.CrossRefPubMedGoogle Scholar
  7. 7.
    Fiorina, P., Shapiro, A. M. J., Ricordi, C., & Secchi, A. (2008). The clinical ımpact of ıslet transplantation. American Journal of Transplantation, 8, 1990–1997.CrossRefPubMedGoogle Scholar
  8. 8.
    Ichii, H., & Ricordi, C. (2009). Current status of islet cell transplantation. Journal of Hepato-Biliary-Pancreatic Surgery, 16, 101–112.CrossRefPubMedCentralPubMedGoogle Scholar
  9. 9.
    Rivas-Carrillo, S. D., Kanamune, J., Iwanaga, Y., Uemoto, S., Daneri-Navarro, A., & Rivas-Carrillo, J. D. (2011). Endothelial cells promote pancreatic stem cell activation during ıslet regeneration in mice. Transplantation Proceedings, 43, 3209–3211.CrossRefPubMedGoogle Scholar
  10. 10.
    Krinsley, J. S., Schultz, M. J., Spronk, P. E., Harmsen, R. E., van Braam, H. F., van der Sluijs, J. P., et al. (2011). Mild hypoglycemia is independently associated with increased mortality in the critically ill. Annals of Intensive Care, 1, 49.CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    McCall, M., & James Shapiro, A. M. (2012). Update on ıslet transplantation. Cold Spring Harbor Perspective Medicine, 2, a007823.CrossRefGoogle Scholar
  12. 12.
    Venstrom, J. M., McBride, M. A., Rother, K. I., Hirshberg, B., Orchard, T. J., & Harlan, D. M. (2003). Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA, 290(21), 2817–2823.CrossRefPubMedGoogle Scholar
  13. 13.
    Takeda, Y., et al. (1998). Protection of islet allografts transplanted together with Fas ligan expressing testicular allografts. Diabetologia, 41(3), 315–321.CrossRefPubMedGoogle Scholar
  14. 14.
    Rackham, C. L., Chagastelles, P. C., Nardi, N. B., Hauge-Evans, C., Jones, P. M., & King, A. J. F. (2011). Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in mice. Diabetologia, 54, 1127–1135.CrossRefPubMedGoogle Scholar
  15. 15.
    Telford Y. Yeung, Karen L. Seeberger, Tatsuya Kin, Adetola Adesida, Nadr Jomha, A. M. James Shapiro, Gregory S. Korbutt. (2012) Human mesenchymal stem cells protect human ıslets from pro-ınflammatory cytokines. PLoS ONE. 7:Issue 5.Google Scholar
  16. 16.
    Ryan, T., Wagner, J. L., Cooney, A., & Chan, L. (2010). Stem cell approaches for the treatment of type 1 diabetes mellitus. Translational Research, 156(3), 169–179.CrossRefGoogle Scholar
  17. 17.
    Solari, M. G., Srinivasan, S., Boumaza, I., et al. (2009). Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. Journal of Autoimmunity, 32, 116–124.CrossRefPubMedGoogle Scholar
  18. 18.
    Park, K. S., Kim, Y. S., Kim, J. H., et al. (2009). Influence of human allogenic bone marrow and cord blood-derived mesenchymal stem cell secreting trophic factors on ATP (adenosine-5′-triphosphate)/ ADP (adenosine-5′-diphosphate) ratio and insülin secretory function of isolated human islets from cadaveric donor. Transplantation Proceedings, 41, 3813–3818.CrossRefPubMedGoogle Scholar
  19. 19.
    Longoni, B., Szilagyi, E., Quaranta, P., et al. (2010). Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation. Diabetes Technology & Therapeutics, 12, 435–446.CrossRefGoogle Scholar
  20. 20.
    Berman, D. M., Willman, M. A., Han, D., et al. (2010). Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates. Diabetes, 59, 2558–2568.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Ding, Y., Xu, D., Feng, G., Bushell, A., Muschel, R. J., & Wood, K. J. (2009). Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and −9. Diabetes, 58, 1797–1806.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Si, Y., Zhao, Y., Hao, H., Liu, J., Guo, Y., Mu, Y., Shen, J., Cheng, Y., Fu, X., & Han, W. (2012). Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivity. Diabetes, 61(6), 1616–1625.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Ilknur Ozturk Unsal
    • 1
    Email author
  • Zeynep Ginis
    • 2
  • Ferda Alparslan Pinarli
    • 3
  • Aynur Albayrak
    • 4
  • Erman Cakal
    • 1
  • Mustafa Sahin
    • 5
  • Tuncay Delibasi
    • 1
    • 6
  1. 1.Department of Endocrinology and Metabolism, Diskapi Yildirim Beyazit Teaching and Research HospitalAnkaraTurkey
  2. 2.Department of Biochemistry, Diskapi Yildirim Beyazit Teaching and Research HospitalAnkaraTurkey
  3. 3.Department of Genetic and Medical Research Center, Diskapi Yildirim Beyazit Teaching and Research HospitalAnkaraTurkey
  4. 4.Department of Pathology, Diskapi Yildirim Beyazit Teaching and Research HospitalAnkaraTurkey
  5. 5.Department of Endocrinology and MetabolismAnkara University School of MedicineAnkaraTurkey
  6. 6.Department of Internal Medicine, School of Medicine (Kastamonu)Hacettepe UniversityAnkaraTurkey

Personalised recommendations